Skip to content

OUR BENEFICIARIES

Why We Chose Our Beneficiaries

Collaboration

We’ve purposefully selected the beneficiaries of the Défi Canderel cancer research fundraiser with a profound vision in mind: to unite researchers, inspire collaboration, and be catalysts in combatting cancer.

We firmly believe that collaboration, not competition, is the key to unlocking breakthroughs in cancer research.

We support both francophone and anglophone university research centres because we believe diversity is a powerful force for change.

By facilitating the exchange of knowledge, ideas, and resources, we empower these institutions to work together harmoniously towards one common goal – ending cancer.

Innovation

These world-renowned academic research centres nurture a new generation of passionate, innovative researchers. They represent the future of cancer research, and investing in their bold initiatives is our way of accelerating progress.

By supporting these visionary researchers, we are achieving faster and more effective results in our quest to eliminate the devastating impact of cancer.

Join us in supporting innovation to make a difference by bringing hope to countless lives.

Montreal Cancer Institute

Focused on advancing cancer prevention, screening, treatment, and improving patients’ quality of life, the Montreal Cancer Institute, affiliated with the CRCHUM’s Cancer Research Axis and the Université de Montréal, has been supporting research for over 75 years, through:

  • Innovative projects
  • Recruiting and training young researchers
  • Educational initiatives

The Institut du cancer de Montréal (ICM) leverages funds from Défi Canderel to promote fundamental and clinical cancer research while preparing the next generation of researchers.

Vision

Give researchers the means to beat cancer by supporting research projects, contributing to the purchase of state-of-the-art equipment, awarding scholarships, and helping to organise scientific conferences.

Mission

To financially support excellence in research related to the Cancer Axis of the Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM).

Values

Commitment, Collaboration, Integrity, Excellence, and Entrepreneurship.

“Thanks to Défi Canderel’s contribution, which is entirely allocated to the general funds of CRCHUM Cancer Axis researchers, research has progressed more rapidly in a number of innovative scientific fields for cancer treatment that are completely transforming patients’ lives.”

Vincent Poitout
DVM, PhD, FCAHS
Director of research and innovation, CHUM

Rosalind and Morris Goodman
Cancer Institute

Through its dedication to interdisciplinary cancer research and fostering a vibrant culture of creativity and collaboration among experts, the GCI advances cancer research by:

  • Funding high-risk-high-payoff studies to provide early data needed to win competitive grants
  • Recruiting new faculty with innovative research programs
  • Providing students with funding to focus on research
  • Helping students share their findings at conferences worldwide

With a focus on educating and training the next generation of leaders, the Rosalind and Morris Goodman Cancer Institute (GCI) leverages funds from Défi Canderel to recruit top global talent and discover breakthroughs in cancer treatment, prevention, and well-being.

Vision

Build a renowned world-class community of researchers committed to improving outcomes for cancer patients through scientific excellence.

Mission

Understand what drives cancer in order to better prevent, diagnose and treat the disease.

Values

Integrity, Creativity, Collaboration and Commitment.

“Funds raised through Défi Canderel support our recruitment of the top talent from across the world to be trained with world leading scientists on cutting-edge equipment. Thank you for empowering these rising stars to discover our next new hope for treatment, prevention, and living well with cancer.”

Dr. Morag Park
Director, Rosalind and Morris Goodman Cancer Centre

Impact Reports

Your donation will be divided equally between two local cancer research centres, McGill University's Rosalind and Morris Goodman Cancer Institute (charitable registration number: 11912 8981 RR0001) and the Institut du cancer de Montréal, affiliated to the Université de Montréal (charitable registration number: 10750 8384 RR0001).

You will receive a tax receipt from both centres, each reflecting 50% of your donation, in early 2024.

For questions or missing receipts, please contact [email protected].

This will close in 0 seconds

Votre don sera divisé également entre deux centres de recherche sur le cancer, l'Institut du cancer de Montréal, affilié à l’Université de Montréal (numéro d’organisme de bienfaisance : 10750 8384 RR0001) et l’Institut du cancer Rosalind et Morris Goodman de l’Université McGill (numéro d’organisme de bienfaisance : 11912 8981 RR0001).

Vous recevrez un reçu fiscal des deux centres, correspondant chacun à 50 % de votre don, en début-2024.

Pour des questions à propos de vos reçus, ou pour des reçus manquants veuillez contacter [email protected].

This will close in 0 seconds